iRhythm Technologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
iRhythm Technologies (NASDAQ:IRTC) is set to announce its financial results for the fourth quarter and full year 2022 on February 23, 2023, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
iRhythm Technologies (NASDAQ:IRTC) is set to announce its financial results for the fourth quarter and full year 2022 on February 23, 2023, after market close. The company will host a conference call at 1:30 p.m. PT/4:30 p.m. ET to discuss the results. iRhythm is recognized for its innovative digital health solutions that utilize wearable biosensors and cloud analytics to deliver clinically actionable information. The upcoming earnings report is anticipated to provide insights into the company’s financial performance and strategic direction.
Details
News Market Reaction – IRTC
The recorded move for IRTC in the trading session of this news was -0.81%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and full year 2022 after the close of trading on Thursday, February 23, 2023. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT/4:30 p.m. ET.
Investors interested in listening to the conference call may do so by accessing the live and archived webcast of the event available on the investors section of the Company’s website at investors.irhythmtech.com.
About iRhythm Technologies, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.
Investor Relations Contact
Stephanie Zhadkevich
(919) 452-5430
investors@irhythmtech.com
iRhythm Media Contact
Morgan Mathis
(310) 528-6306
irhythm@highwirepr.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.